Genocea: Genocea cuts two-thirds of staff, explores a sale
The Cambridge cancer drug developer said it's laying off 65% of its staff and looking for sale and merger opportunities.
Read full article »
Genocea is a pharmaceutical company that researches and develops T-cell based therapies for the treatment of cancer.
Read more